Abstract
We investigated the efficacy of intratumoral administration of biological response modifiers (BRM) in induction of in vitro sensitized (IVS) cells for adoptive immunotherapy of the poorly immunogenic MCA 102 sarcoma and B16-BL6(BL6) melanoma. We used the bacterial immunoadjuvant Nocardia rubra cell wall skeleton (N-CWS), and a streptococcal preparation, OK-432, for MCA 102 and BL6, respectively. After C57BL/6(B6) mice were inoculated subcutaneously (s.c.) with viable MCA 102 or BL6 tumor cells in the foot-pad, mice were injected intratumorally (i.t.) with N-CWS ranging from 10 to 400 micrograms or OK-432 ranging from 1 to 100 micrograms. Draining popliteal lymph nodes (LN) were harvested 7 days after i.t. administration of BRM, and LN cells were cultured with irradiated tumor cells in the presence of IL-2 for 11 days. These IVS cells (7.5 x 10(6) or 2 x 10(6)) were transferred intravenously (i.v.) to B6 mice with 4 day pulmonary metastases established by i.v. injection of viable MCA 102 cells (1 x 10(6)) or viable BL6 cells (3 x 10(5)). The mice were also received intraperitoneally 4 x 10(4) IU/day of IL-2 for 4 days after adoptive transfer. The transfer of IVS cells from mice immunized by i.t. injection of 100 micrograms of N-...Continue Reading
References
Jun 1, 1992·Surgical Oncology·J D GeigerA E Chang
Aug 1, 1990·Cellular Immunology·K SakaiS Shu
May 1, 1989·Immunology Letters·H FukuiA Uchida
Jan 1, 1986·Microbiology and Immunology·T NodaN Ishida
Mar 1, 1985·Cancer Research·K YasumotoY Yamamura
Dec 1, 1987·The Journal of Experimental Medicine·J S WeberS A Rosenberg
Jan 1, 1986·Cancer Immunology, Immunotherapy : CII·T MasunoY Yamamura
Apr 1, 1986·Immunopharmacology·A YamamotoI Urushizaki
Sep 1, 1986·Journal of Surgical Oncology·S D NathansonM Lee
Jan 1, 1985·International Journal of Immunopharmacology·O IchimuraN Ishida
Mar 15, 1982·Cellular Immunology·M SaitoN Ishida
Feb 15, 1984·International Journal of Cancer. Journal International Du Cancer·M SaitoN Ishida
Jan 15, 1984·Cancer·Y Watanabe, T Iwa
Feb 1, 1980·Cancer·A Uchida, T Hoshino
Apr 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·J D GeigerA E Chang